| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |